© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Phil Catudal credits his early cancer experience with his motivational approach to wellness.
Using mouse models, the study focused on why asparaginase—a natural enzyme used as a drug to treat the blood cancer—doesn’t always work.
Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.
The professional wrestler has lived with the cancer since age 22.
Timothy Brown may have company after a man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.
Venclexta alone or in combination with Rituxan improved progression-free survival in patients with chronic lymphocytic leukemia.
Researchers believe their greater understanding of leukemia stem cells will lead to more treatment options for people with the blood cancer.
A look back at some of the major news stories we covered this year.
Tafinlar plus Mekinist shrank tumors in people with biliary tract cancer and adenocarcinoma of the small intestine.
Asparlas approved for children and young adults with acute lymphoblastic leukemia.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
